Methicillin-Resistant Staphylococcus Aureus Infections – Epidemiology – Asia Pacific Data

Methicillin-Resistant Staphylococcus aureus Epidemiology Abstract

DRG Epidemiology's coverage of methicillin-resistant staphylococcus aureus comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the incidence of methicillin-resistant staphylococcus aureus for each country, as well as annualized case counts projected to the national population.

DRG Epidemiology's methicillin-resistant staphylococcus aureus forecast will answer the following questions:

How will changes in the levels of exposure to known risk or protective factors affect the number of methicillin-resistant staphylococcus aureus events per year?

Of all people diagnosed with methicillin-resistant staphylococcus aureus, how many in each country across the major mature pharmaceutical markets are drug-treated?

How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of methicillin-resistant staphylococcus aureus over the forecast period?

All forecast data are available on the DRG Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.

DRG Epidemiology provides at least ten years of forecast data for the following methicillin-resistant staphylococcus aureus patient populations:

Diagnosed MRSA Events by Treatment

Methicillin-Resistant Staphylococcus aureus Diagnosed MRSA Events

Methicillin-Resistant Staphylococcus aureus Diagnosed MRSA Events – BSI

Methicillin-Resistant Staphylococcus aureus Diagnosed MRSA Events – cIAI

Methicillin-Resistant Staphylococcus aureus Diagnosed MRSA Events – cSSSI

Methicillin-Resistant Staphylococcus aureus Diagnosed MRSA Events – HAP

Methicillin-Resistant Staphylococcus aureus Diagnosed MRSA Events – HCAP

Methicillin-Resistant Staphylococcus aureus Diagnosed MRSA Events – Nosocomial Pneumonia

Methicillin-Resistant Staphylococcus aureus Diagnosed MRSA Events – SSI

… and more (details available on request).

Note: coverage may vary by country and region.

Table of contents

  • Methicillin-Resistant Staphylococcus Aureus Infections - Epidemiology - Asia Pacific Data
    • Introduction
      • Key Findings
        • Overview
          • Hospital-Treated Methicillin Resistant Staphylococcus Aureus Events by Infection Site, 2017
      • Epidemiology Data
      • Methods
        • Diagnosed MRSA Events
        • Diagnosed MRSA Events - UTI
        • Diagnosed MRSA Events - BSI
        • Diagnosed MRSA Events- NP
        • Diagnosed MRSA Events - SSI
        • Diagnosed MRSA Events - cSSSI
      • Reference Materials
        • Literature Review
          • Studies Included in the Analysis of MRSA
          • Studies Excluded from the Analysis of MRSA
        • Risk/Protective Factors
          • Risk/Protective Factors for MRSA
        • Bibliography

    launch Related Market Assessment Reports